Latest news
FDA feedback supports new testing path for therapy in MS relapses - Multiple Sclerosis News TodayMultiple Sclerosis News Today · Thu, 06 Aug 2026 22:51:52 GMTDaratumumab Induces High Responses Despite Relapse in Patients With iTTP - Docwire NewsDocwire News · Thu, 06 Aug 2026 21:01:16 GMTInternational study identifies promising therapy to prevent relapses in rare neurological disease - newsnetwork.mayoclinic.orgnewsnetwork.mayoclinic.org · Thu, 06 Aug 2026 15:10:47 GMTOculis Receives Positive FDA Feedback for Privosegtor Development in Acute Multiple Sclerosis Relapses - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 08:10:00 GMTRevisiting classical genetic subtypes reveals subtype-specific relapse patterns and MRD prognostic relevance in pediatric acute lymphoblastic leukemia - nature.comnature.com · Mon, 27 Jul 2026 08:20:09 GMT